Whit Mayo
Stock Analyst at Leerink Partners
(2.53)
# 2,267
Out of 4,944 analysts
166
Total ratings
51.52%
Success rate
10.31%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $294.43 | +5.29% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $7.30 | -65.75% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.73 | +13.05% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $7.57 | +5.68% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $12.67 | +97.32% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $281.99 | -11.34% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $119.13 | -16.06% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $22.39 | -33.01% | 1 | Feb 20, 2024 | |
| UNH UnitedHealth Group | Maintains: Outperform | $625 → $560 | $271.81 | +106.03% | 11 | Jun 14, 2023 | |
| UHS Universal Health Services | Upgrades: Outperform | n/a | $178.51 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $111.50 | -13.00% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $287.10 | +16.68% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $100.98 | -15.82% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $390.46 | -26.75% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $23.56 | +69.78% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $21.02 | +85.54% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.62 | -42.75% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.05 | +2,757.14% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $15.50 | +3.23% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $171.87 | -68.00% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $20.77 | +396.03% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $90.98 | +92.35% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $14.76 | +28.73% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.77 | +44.40% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $272.54 | -25.52% | 2 | May 1, 2018 |
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $294.43
Upside: +5.29%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $7.30
Upside: -65.75%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.73
Upside: +13.05%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $7.57
Upside: +5.68%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $12.67
Upside: +97.32%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $281.99
Upside: -11.34%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $119.13
Upside: -16.06%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $22.39
Upside: -33.01%
UnitedHealth Group
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $271.81
Upside: +106.03%
Universal Health Services
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $178.51
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $111.50
Upside: -13.00%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $287.10
Upside: +16.68%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $100.98
Upside: -15.82%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $390.46
Upside: -26.75%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $23.56
Upside: +69.78%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $21.02
Upside: +85.54%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.62
Upside: -42.75%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.05
Upside: +2,757.14%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $15.50
Upside: +3.23%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $171.87
Upside: -68.00%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $20.77
Upside: +396.03%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $90.98
Upside: +92.35%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $14.76
Upside: +28.73%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.77
Upside: +44.40%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $272.54
Upside: -25.52%